Meet mild, reversible acute kidney injury (AKI) -- a sudden loss of kidney function that can go away within 24 hours or, if unchecked, can lead to chronic kidney failure, dialysis or transplant! It ...

A 65-year-old man presented to the ED with 1 day of acute onset mid-thoracic and low back pain, difficulty ambulating and ...

The most common cause of chronic pain in dogs is arthritis (1), and although they may be stiff and reluctant to walk, the ...

Whether you’re injured or you injure someone else in a car accident, it’s a good idea to know how much common car accident ...

Cubs non-roster invitee Brandon Birdsell is also dealing with an injury, manager Craig Counsell announced Monday.

Background FIFA has surveyed match injuries in its tournaments since 1998. Aim To analyse the incidence and characteristics of match injuries incurred during the 2014 FIFA World Cup in comparison to ...

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by ...

So the thought is, if providers start this medication where it doesn’t have that same dependence potential, it could act as a safer medication overall for acute pain,” McKay said. During its trial ...

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, the acting director of the FDA's Center for Drug Evaluation and ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with acute pain. The FDA has approved the non-opioid, highly selective ...

The drug is for moderate to severe acute pain. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe ...